Molina Healthcare, Inc. (MOH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Robbins Geller Rudman & Dowd LLP

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims related to undisclosed adverse financial conditions and misleading earnings guidance during the specified class period [1][4][5]. Company Summary - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals through Medicaid, Medicare, and state insurance marketplaces [3]. - The company has been accused of failing to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [4]. Financial Performance - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [5]. - Following this announcement, the company's stock price experienced a decline, reflecting investor concerns over its financial outlook [5]. - On July 23, 2025, Molina Healthcare further cut its full-year 2025 earnings guidance, reporting a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and projecting adjusted earnings of no less than $19.00 per diluted share for the full year [6]. - The stock price fell nearly 17% after this announcement, indicating significant market reaction to the revised earnings outlook [6]. Legal Proceedings - The class action lawsuit allows investors who purchased Molina Healthcare securities during the class period to seek appointment as lead plaintiff, representing the interests of all class members [7]. - Robbins Geller Rudman & Dowd LLP is the law firm leading the class action, which has a strong track record in securities fraud litigation [8].